Esophageal squamous cell carcinoma (ESCC) is endemic in east Africa and is a leading cause of cancer death among Kenyans. The asymptomatic precursor lesion of ESCC is esophageal squamous dysplasia (ESD). We aimed to determine the prevalence of ESD in asymptomatic adult residents of southwestern Kenya.
INTRODUCTION
Esophageal cancer is the sixth leading cause of cancer death in the world ( 1 ) . Endemic regions with the highest rates of this cancer are found in central and eastern Asia and in eastern and southern Africa, and in these areas, about 90% of the cases are esophageal squamous cell carcinoma (ESCC) (1) (2) (3) . Esophageal cancer has a very poor prognosis because patients only develop symptoms at an advanced stage. Th e 5-year relative survival rate for esophageal cancer in the United States is 18% ( 4 ) , and in most high-risk areas where the medical infrastructure is less well developed it is <5% ( 5 ). To improve this survival, it is necessary to screen asymptomatic adults for curable precursor lesions and early-stage cancers ( 6, 7 ) .
ESCC is one of the leading causes of cancer among Kenyan adults, and it accounts for 31% of new cancer diagnoses at Tenwek Hospital in southwestern Kenya ( 3 ) where this study was conducted. Esophageal squamous dysplasia (ESD) is the asymptomatic precursor lesion of ESCC, and the risk of progression depends greatly on the degree of dysplasia (8) (9) (10) . Th e prevalence of ESD is around 30% in some asymptomatic high-risk Chinese Esophageal Squamous Dysplasia is Common in Asymptomatic Kenyans: A Prospective, Community-Based, Cross-Sectional Study populations ( 11, 12 ) , but the prevalence of ESD in asymptomatic high-risk African populations is unknown.
Various methods for diagnosis of ESD are available. Esophageal exfoliative cytology, endoscopy performed with standard white light, and random esophageal biopsy are not suffi ciently sensitive to be used for population screening (11) (12) (13) . ESD is better detected by Lugol's iodine chromoendoscopy or narrow band imaging with subsequent directed biopsy (13) (14) (15) . Lugol's chromoendoscopy, with biopsy of unstained regions, has the highest diagnostic yield in Asian studies ( 13, 14 ) . During endoscopy, normal esophageal mucosa stains darkly with iodine, while regions of ESD or esophagitis appear as "unstained lesions" (USLs).
Screening programs to detect and treat asymptomatic ESD have been shown to prevent cancer deaths in Asia ( 6, 7, 16 ) , and knowledge of the baseline prevalence and risk factors for ESD in east Africa could help determine whether similar screening programs are warranted in this region. In this study, we aimed to determine the prevalence of ESD in asymptomatic adult residents. Secondary objectives were to characterize the histological grade and location of dysplasia, to explore the sensitivity and specifi city of Lugol's USLs for identifying mucosal areas with dysplasia, and to explore the impact of various risk factors (including age, sex, ethnicity, family history, tobacco use, ethanol use, and environmental exposures) on the prevalence of ESD.
METHODS

Study Design and Participants
Between 2010 and 2013, we prospectively recruited 305 asymptomatic adult persons living in villages located within 50 km of Tenwek Hospital (latitude −0.745252, longitude 35.355892), in Bomet County, Kenya, which has a population of 780,000, and assessed the presence of ESD by performing upper gastrointestinal endoscopy with Lugol's chromoendoscopy and mucosal biopsy in all study participants. Th is geographic area was divided into three traditional residence zones, which together are demographically representative of Bomet County: Zone A (a highland fertile area with extensive tea and corn farms), Zone B (a dry and sandy area with wheat farms and herds of cattle and goats), and Zone C (a mixed dry and fertile area) ( Figure 1 ). Th ese zones are a traditional way to divide Bomet County, based on diff erences in climate, economic activities, agriculture, and animal husbandry but not ethnicity. We aimed to enroll approximately equal numbers of subjects from each zone, gender, and age group (by decade of life). Recruitment went on simultaneously in the three zones and was carried out in the villages of residence. Inclusion criteria included residence within 50 km of Tenwek Hospital, age 20-79 years, and a signed informed consent. Persons were specifi cally questioned about symptoms of dysphagia, odynophagia, hematemesis, or recent weight loss, and persons with any of these symptoms were excluded. Other exclusion criteria included allergy to iodine or lidocaine and preexisting medical conditions that would increase the risk of endoscopy (including bleeding disorders, heart arrhythmias, diabetes, lung disease or bleeding problems, or stroke). Th ese inclusion and exclusion criteria were satisfi ed at the time of study enrolment.
Th e study was initially approved by the overall administrative head for the county. Subsequently, 23 village chiefs in the study region were approached regarding potential involvement of their village, and all who were approached gave permission. Once a chief decided that the study could include his village, study staff visited the village on a preannounced date and explained the study to all adult residents who chose to attend an informational meeting. Th e purpose and nature of the study were fully explained at these meetings, including the fact that participants would be evaluated for the presence of esophageal dysplasia and cancer. Aft er the group informational meeting, those who wished to enroll had the study explained to them again individually and then they were asked to sign a written informed consent. We estimate that about half of those who came to the informational meetings enrolled in the study. On the day of their study participation, the fasting study participants were transported to Tenwek Hospital for the study procedures, and they received a meal aft er recovering from endoscopy.
Procedures
On arrival at Tenwek Hospital, participants completed a questionnaire and provided blood and urine samples. Th e questionnaire collected information on demographic characteristics, living environment, farming practices, medical history, alcohol and tobacco use and dietary practices.
Participants then underwent video endoscopy of the esophagus (EG 250 WR5 Gastroscopes, Fujinon, Tokyo, Japan) with mapping and biopsy of visible lesions before and aft er staining of the mucosa with 1.4% Lugol's iodine solution, as well as two random biopsies of normal-appearing mid-esophageal mucosa. Th e endoscopic procedures were conducted under conscious sedation (intravenous diazepam or midazolam and fentanyl), with standard vital signs monitoring and postendoscopy care. Th e study PI (MM) performed approximately 80% of the endoscopies, and four other endoscopists (SB, JL, RW, MT) performed the rest. During all endoscopies, two of the study endoscopists were present in the room, and they agreed on the locations and descriptions of the USLs and biopsy sites. Aft er recovery from endoscopy, participants were asked to grade the level of discomfort they experienced. Endoscopic fi ndings were recorded using standardized data forms, and abnormalities were characterized by their location (distance from the incisors and gastroesophageal junction), longitudinal extent, circumferential extent on the "clock face" of the esophageal lumen, estimated maximum diameter, macroscopic appearance, and uptake of Lugol's iodine.
Th e histology of the study biopsies was read at the Department of Human Pathology, University of Nairobi, Nairobi, Kenya (JG and WW) and at the National Cancer Institute in Bethesda, MD (SMD), and discrepancies were adjudicated by joint consultation. Specimens were diagnosed using previously described criteria ( 17 ) . Squamous dysplasia was characterized by nuclear atypia, loss of normal cellular polarity, and abnormal tissue maturation in the lower third (mild), lower two-thirds (moderate), or all thirds (severe) of the epithelium. Moderate and severe dysplasia were combined into one "high-grade" dysplasia category for some data analyses. All participants were informed of their endoscopic and biopsy fi ndings and those with ESD were counselled to pursue endoscopic or surgical therapy as appropriate. Th e study was approved by the Tenwek Hospital IRB and the Ethics Review Committee of the University of Nairobi protocol number P172/06/2010. (Clinicaltrials.gov identifi er NCT01981876).
Statistical Analysis
Th e data were analyzed both by biopsy site and by participant. For biopsy site analysis, we compared the endoscopic appearance, before and aft er staining, to the worst histological diagnosis from each site. We estimated the sensitivity and specifi city for identifying mucosal areas with dysplasia using white-light endoscopy (before staining) and aft er staining with Lugol's iodine solution. We also evaluated the impact of mucosal staining on identifying patients with dysplasia.
In the participant analysis, participants were characterized based on their worst diagnosis as either having dysplasia (mild, moderate, or severe dysplasia) or not (normal epithelium or esophagitis). We calculated the overall and 10-year age-specifi c prevalence of ESD. We tested for diff erences in participant charac teristics between those with and without dysplasia using χ 2 test and Fisher's exact test. Multivariate logistic regression was used to estimate odds ratios (ORs) and 95% confi dence intervals (95% CIs) for ESD. All statistical tests were two-sided, and P <0.05 was considered statistically signifi cant. Analyses were performed using SAS, version 9.4 (SAS Institute, Cary, NC).
RESULTS
Of the 333 enrolled subjects, 20 did not come to Tenwek Hospital for their study procedures ( Figure 2 ). Of the remaining 313 participants, 305 (92%) completed the study endoscopy and were included in the analyses. Seven participants were excluded at the time of interview or endoscopy as shown in Figure 2 , including two who were found to have non-ESCC malignancies during study endoscopy (one laryngeal cancer, one gastric antral cancer) and did not undergo chromoendoscopy. In addition, histology slides were missing for one participant. Participant age ranged from 20 to 79 years, and the mean age (s.d.) was 46.7 (15.5) years. All were of Kalenjin ethnicity, and 163 (53%) were male ( Table 1 ). Nineteen percent of the participants reported no discomfort during endoscopy, 80% reported mild discomfort, <1% reported moderate discomfort, and none reported severe discomfort. Th ere were no adverse events related to study procedures.
Fift y-two (7.4%) of the 698 sites biopsied in the study showed ESD, including 43 with mild dysplasia, 8 with moderate dysplasia, and 1 with severe dysplasia. Eight subjects had dysplasia at more than one site, and no invasive ESCC was detected. Of the 52 dysplastic lesions, 2 (4%) were found in the upper third of esophagus (<25 cm from the incisors), 30 (58%) in the middle third (25-30 cm from the incisors), and 20 (38%) in the lower third (>30 cm from the incisors).
Categorized by their worst biopsy diagnosis, 115 (37.7%) participants had normal squamous mucosa, 146 (47.9%) had esophagitis, 35 (11.5%) had mild squamous dysplasia, 8 (2.6%) had moderate dysplasia, and 1 (0.3%) had severe dysplasia. Overall, 44 of the 305 participants had ESD, a prevalence of 14.4% (95% CI: 10-19%). Th e prevalence of ESD increased with age and exceeded 20% in men aged >50 years and women aged >60 years ( Table 2 ). Although the dysplasia rate steadily increased with age among men, this was not apparent among women, possibly owing to the modest number of dysplasia cases in the women. Table 3 shows the histology results from the 698 biopsy sites by endoscopic appearance before and aft er staining with Lugol's
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iodine solution. Th irty-nine lesions were detected by white-light endoscopy, four of which were dysplastic (three mild and one moderate dysplasia). Th e sensitivity of white-light endoscopy for detecting areas of dysplasia was 7.7% (95% CI: 2.2-18.6), the specifi city was 94.6% (95% CI: 92.5-96.2), the positive predictive value was 10.3% (95% CI: 2.9-24.2), and the negative predictive value was 92.7% (95% 90.5-94.6). Th e sensitivity for detecting highgrade (moderate or severe) dysplasia was 11.1% (95% CI: 1.8-48.3) and the specifi city was 94.5% (95% CI: 95.5-96.1).
Using iodine chromoendoscopy, 231 USLs were detected ( Table 3 , Figure 3 ), 35 of which were dysplastic (29 mild, 5 moderate, and 1 severe dysplasia). In contrast to reports from China, we rarely saw large USLs such as those shown in Figure 3c ,d . In 15% of cases, USLs coalesced into a mosaic pattern ( Figure 3d ) . Th e sensitivity of chromoendoscopy for detecting areas of dysplasia was 67.3% (95% CI: 53.9-79.7), the specifi city was 69.7% (95% CI: 65.9-73.2), the positive predictive value was 15.2% (95% CI: 10.8-20.4), and the negative predictive value was 96.4% (95% CI: 94.2-97.9). Th e sensitivity and specifi city for detecting high-grade dysplasia were similar (66.7%, 95% CI: 30.1-92.1 and 67.3, 95% CI: 63.7-70.8, respectively). Table 4 shows the impact of staining on identifying patients with dysplasia. In 9.1% of the patients with dysplasia, the worst histological lesion was visible by white-light endoscopy; in 63.6%, the worst lesion was identifi ed only aft er staining with Lugol's iodine; and in 27.3%, the worst lesion was identifi ed in normal-appearing and normally staining mucosa. Of the nine patients with high-grade dysplasia, only one was identifi ed before staining, four were identifi ed only aft er staining, and three were identifi ed by random biopsies of normal-appearing mucosa.
Th e multivariate analysis of risk factors for ESD ( Table 5 ) included factors that were statistically signifi cant in Table 1 and factors that have been associated with dysplasia risk in previous studies. In the multivariate analysis, residence location was significantly associated with ESD (Zone A OR 2.37, 95% CI: 1.06-5.30, and Zone B OR 2.72, 95% CI: 1.12-6.57, compared with Zone C), and the association of alcohol use and ESD was nearly signifi cant (OR 2.48, 95% CI 0.98-6.29). Postprimary education, tobacco use, and family history of cancer were not signifi cantly associated with the prevalence of ESD. In a separate post-hoc analysis, the histological fi nding of esophagitis did not aff ect the likelihood of dysplasia,
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Severe n=1 Excluded subjects n =7 • Subject withdrew n=2 • Pregnant n=1 • Varices present, no biopsies taken n=1 • Gastric outlet obstruction n=1 owing to peptic disease • Non-ESCC malignancies found n=2 endoscopic biopsies found ESD in only 0.7% of patients ( 18 ); autopsy studies conducted in South Africa demonstrated ESD in 3.2-7.5% of black residents ( 19, 20 ) . Th ese early studies, which were performed over two decades ago, did not use current detection methods. Our study probably underestimated the true prevalence of dysplasia, because over a quarter of detected cases were found on random biopsy of normal-appearing and normally staining midesophageal mucosa, and similar dysplastic regions elsewhere in the esophagus would have been missed. Our observed ESD prevalence was lower than the 22-31% prevalence reported from most chromoendoscopy screening studies in high-risk populations in China ( 11, 12, 21 ) , and it was higher than the 6% ESD prevalence found in the one similar screening study reported from a high-risk population in Iran ( 22 ) . Th is variation probably refl ects population diff erences in underlying ESCC incidence, but it may also be partly due to other population diff erences (e.g., the age of those screened), diff erences in endoscopic techniques or the pathology criteria used, or diff erences in cancer biology in these countries. which was present in 28/174 subjects with histological esophagitis vs. 16/131 without esophagitis ( P =0.41).
DISCUSSION
ESD is the precursor lesion of ESCC. ESD is asymptomatic and diffi cult to detect by standard white-light endoscopy. Th is is the fi rst African study to use Lugol's iodine chromo endoscopy to screen for ESD. We found ESD in 14.4% of asymptomatic volunteers, including 35 (11.4%) with mild dysplasia and 9 (3%) with advanced (moderate or severe) dysplasia. Th e prevalence of ESD increased with age and was ≥20% in men aged ≥50 years and women aged ≥60 years. Geographic zone of residence was statistically associated with the prevalence of ESD. ESD is suffi ciently common in our region to justify population-based screening, targeting persons at highest risk.
Although ESCC is endemic throughout much of east and southern Africa, there is little prior published data concerning ESD in the region. A study from South Africa that utilized 
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Compared with these previous endoscopic screening studies from other high-risk areas, we saw a higher prevalence of ESD among young participants (8% in those aged <40 years), in keeping with our prior fi nding that a higher proportion of ESCC cases in southwestern Kenya occur in young people ( 3 ). Compared with white-light endoscopy, Lugol's chromoendoscopy signifi cantly improved the sensitivity of detecting ESD. Th is is similar to the results of previous reports (13) (14) (15) . In our study, Lugol's chromoendoscopy had a 67% sensitivity for detecting all ESD, and the same 67% sensitivity for detecting advanced dysplasia (the most important target for screening) ( 10, 17, 23 ) . Th ese fi gures were signifi cantly less than the 82% sensitivity for all ESD and the 95% sensitivity for high-grade ESD that were previously reported from China ( 13 ) . Possible reasons for these diff erences include suboptimal Lugol's staining in some participants, diff erent endoscopic equipment and personnel, population diff erences in how iodine stains the mucosa, or chance variation. previous studies have shown that stratifi cation based on such factors achieves only modest effi ciencies ( 23, 24 ) . What is probably needed is the development and use of a less invasive and less costly non-endoscopic primary screening method that would reliably prescreen the population, identifying the individuals at highest risk and triaging them to endoscopy. Strengths of this study include its prospective, communitybased design, with enrolment of asymptomatic participants who were not seeking health care or undergoing endoscopy for clinical indications. In addition, the multidisciplinary study team brought extensive endoscopy, pathology, and ESD research experience to bear on this work. Limitations of this study include limiting the study catchment area to one county in Kenya and a 50-km radius. Th is was done in order to obtain a truly community-based assessment of a region; however, it is unclear if our results apply to other regions and ethnicities. Additionally, participants were fully informed about the nature of the study before enrolment, introducing the possibility of selection bias. It is unlikely that self-selection owing to unreported symptoms was common as dysplasia is completely asymptomatic and no occult cancers were found. Family history of cancer, however, could have motivated volunteering for screening, and this would have introduced a referral bias.
In conclusion, endoscopic screening of asymptomatic adults for ESD and early esophageal cancer is feasible, safe, and patientacceptable in this high-risk African population. Lugol's staining increases the sensitivity of screening and is necessary for visual detection of most cases of squamous dysplasia but has only moderate sensitivity and specifi city for detection of ESD in our region. Further investigations are needed to understand the diff erences in dysplasia prevalence in the diff erent geographic regions of our study area. Findings from this study will help to refi ne the design of screening and intervention programs for ESD and esophageal cancer in east Africa.
In our study, residence location was a signifi cant risk factor for ESD. Th ere were three main residence zones, which were diff erent in terms of climate, soil, agriculture, and animal husbandry. It is not clear why residents of zones A and B had a higher risk of ESD, and the multivariate model using the exposures listed in Table 1 shows that family history, tobacco, and alcohol cannot explain the diff erence in prevalence between the regions. Th is notable diff erence in prevalence has stimulated future research to understand this diff erence.
Th e high prevalence of dysplasia in this population justifi es a screening program for detection and subsequent endoscopic treatment. However, endoscopic screening at a population level would be too costly and resource-intensive in our setting. Th us there is a need to risk-stratify the population so that only the highest-risk people need to undergo endoscopy. From our study results, it appears that some risk stratifi cation could be achieved by targeting older age groups and individuals with certain risk factors such as alcohol drinking or residence in certain geographic regions, but Table. b At least once per day for 6 months. c At least once per week for 6 months.
